Helmut Salih is author on more than 200 scientific publications and inventor on >10 patents. His research focuses on novel strategies for cancer immunotherapy, and he has translated >10 self-developed therapeutic concepts until the stage of clinical evaluation, serving as coordinating investigator in the respective trials.